Exploring the Lived Experiences of Hospitalized Individuals with Substance Use Disorder and Co-occurring Anxiety Disorder: A Qualitative Phenomenological Analysis

References

[1] American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing.

[2] Balmuth, E. A., Iyer, S., Scales, D. A., & Avery, J. (2024). Perspectives and recommendations from hospitalized patients with substance use disorders: A qualitative study. Journal of General Internal Medicine, 39(11), 2087–2096. https://doi.org/10.1007/s11606-024-08745-3

[3] Boland, E. M., Staines, A., & Joyce, M. (2019). Anxiety and substance use comorbidity: Longitudinal associations and outcomes. Journal of Dual Diagnosis, 15(3), 145–158.

[4] Drake, R. E., O’Neal, E. L., & Wallach, M. A. (2019). A systematic review of integrated treatment for dual disorders. Psychiatric Services, 70(2), 1–10.

[5] Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2020). Treatment of substance use disorders with co-occurring psychiatric conditions. Addictive Behaviors, 109, 106469.

[6] Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2023). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 145, 107772.

[7] Khantzian, E. J. (2017). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 25(2), 1–13.

[8] Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773. https://doi.org/10.1016/S2215-0366(16)00104-8

[9] Lin, E. R. H., Veenker, F. N., Manza, P., Yonga, M. V., Abey, S., Wang, G. J., & Volkow, N. D. (2024). The limbic system in co-occurring substance use and anxiety disorders: A narrative review using the RDoC framework. Brain Sciences, 14(12), 1285. https://doi.org/10.3390/brainsci14121285

[10] Moustafa, A. A., Tindle, R., & Frydecka, D. (2021). Neurocognitive mechanisms in addiction and anxiety disorders. Neuroscience & Biobehavioral Reviews, 125, 150–162.

[11] Rajab, D., Fujioka, J. K., Walker, M., Bartels, S. A., MacKenzie, M., & Purkey, E. (2023). Emergency department care experiences among people who use substances: A qualitative study. International Journal for Equity in Health, 22(1), 248. https://doi.org/10.1186/s12939-023-02050-x

[12] Smith, J. P., & Randall, C. L. (2017). Anxiety and alcohol use disorders: Comorbidity and treatment considerations. Clinical Psychology Review, 55, 70–80.

[13] Substance Abuse and Mental Health Services Administration. (2014). SAMHSA’s concept of trauma and guidance for a trauma-informed approach. U.S. Department of Health and Human Services.

[14] Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders. Depression and Anxiety, 35(9), 851–860. https://doi.org/10.1002/da.22771

[15] Velez, C. M., Nicolaidis, C., Korthuis, P. T., & Englander, H. (2017). “It's been an experience, a life learning experience”: A qualitative study of hospitalized patients with substance use disorders. Journal of General Internal Medicine, 32(3), 296–303. https://doi.org/10.1007/s11606-016-3919-4

[16] Volkow, N. D., Koob, G. F., & McLellan, A. T. (2019). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371. https://doi.org/10.1056/NEJMra1511480

@article{1718928,
      author = {Osuntoyinbo Bayo Patrick, Bamigboye Theresa Olaitan, Afolayan Joel Adeleke, Oladayo Damilola Akinwale},
      title = {Exploring the Lived Experiences of Hospitalized Individuals with Substance Use Disorder and Co-occurring Anxiety Disorder: A Qualitative Phenomenological Analysis},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {12},
      pages = {1642-1647},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718928.pdf},
      abstract = {Substance use disorder (SUD) frequently co-occurs with anxiety disorders, leading to complex clinical presentations, poorer treatment outcomes, and increased relapse risk. However, limited qualitative research has explored the lived experiences of hospitalized individuals with this dual diagnosis. This study explored the lived experiences of hospitalized individuals diagnosed with SUD and co-occurring anxiety disorders, focusing on their perceptions of illness, hospitalization, stigma, coping strategies, treatment experiences, and recovery expectations. A qualitative phenomenological design was used. Semi-structured interviews were conducted with 15 hospitalized adults diagnosed with both conditions. Data were analyzed using Braun and Clarke’s thematic analysis framework, and trustworthiness was ensured through member checking, and reflexive journaling. Five themes emerged: (1) Living in a Cycle of Fear and Dependence, (2) The Burden of Stigma and Self-Blame, (3) Hospitalization as Both Refuge and Restriction, (4) Searching for Understanding and Compassionate Care, and (5) Recovery as an Ongoing Journey. Participants described using substances to manage anxiety, experiencing stigma in healthcare settings, and facing uncertainty about recovery. The study concludes that individuals with co-occurring SUD and anxiety disorders experience significant psychological distress compounded by stigma and fragmented care. Integrated, trauma-informed, and patient-centered approaches are essential to improve treatment outcomes and recovery experiences.},
      keywords = {Substance Use Disorder, Anxiety Disorder, Hospitalization, Lived Experience, Phenomenology, Dual Diagnosis},
      month = {June},
      doi = {https://doi.org/10.64388/IREV9I12-1718928}
  }